Good Faith Exam
for Tirzepatide
Nurse-Owned and Clinician-Led
Nationwide Coverage
Independent Medical Judgment
For Startups
For Established Practices
What Is a Good Faith Exam for Tirzepatide
Tirzepatide is a dual GIP and GLP-1 receptor agonist. That dual mechanism makes it one of the most effective weight loss medications currently available. It is also a prescription drug with a contraindication profile that requires clinical review before it is prescribed.
A good faith exam for tirzepatide is a medical evaluation conducted by a licensed physician before the medication is prescribed. The physician reviews the patient’s health history, current medications, metabolic and endocrine conditions, cardiovascular risk, and contraindications specific to this drug class.
Key contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, prior pancreatitis, significant gastrointestinal conditions, and concurrent hypoglycemic medications. These are the clinical factors the evaluation identifies before a prescription is written.
Tirzepatide good faith exam documentation establishes the clinical record that supports every prescribing decision. GoodFaithExams.com delivers that documentation online without disrupting the workflow.
Why Tirzepatide GFE Requirements Exist
Who Can Perform It
What to Expect
Patient Intake
Provider Evaluation
Clinical Decision
Documented Outcome
How GoodFaithExams.com Makes It Simple
Pricing
$26.99 per exam.
No hidden fees. No monthly minimums. No contracts.
Who This Is and Is Not For
Good fit:
- Weight loss practices prescribing tirzepatide, telehealth platforms operating across multiple states, practices offering Mounjaro, Zepbound, or compounded tirzepatide.
Not for:
- Clinics looking for shortcuts, businesses seeking legal advice, teams that do not want licensed provider involvement.